Abstract
Central retinal vein occlusion (CRVO) and branch retinal vein occlusion (BRVO) are retinal vascular diseases that may cause significant ocular morbidity and vision loss (David et al. 1988; Rogers et al. 2010). It commonly affects men and women equally and occurs predominantly in the age of 65 years (Lang and Handel 1992; Noma et al. 2005 and 2008; Chen et al. 1995; Iturralde et al. 2006). Younger individuals which present with a clinical picture of CRVO may have an underlying inflammatory etiology (Fekrat and Finkelstein 1999). Most common risk factors associated with CRVO and BRVO are systemic hypertension, diabetes, hyperlipidemia, glaucoma, carotid insufficiency, smoking, and age-related atherosclerosis (Noma et al. 2005; Sunness et al. 1991). Other associated factors are listed in Table 11.1.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Bandello F, Tavola A, Pierro L (1998) Axial length and refraction in retinal vein occlusions. Ophthalmologica 212:133–135
Berker N, Batman C (2008) Surgical treatment of central retinal vein occlusion. Acta Ophthalmol 86:245–252
Central Retinal Vein Occlusion Study Group (1993) Central vein occlusion study of photocoagulation therapy. Baseline findings. Central Vein Occlusion Study Group. Online J Curr Clin Trials Doc No 95.
Chen JC, Klein ML, Watzke RC, Handelman IL, Robertson JE (1995) Natural course of perfused central retinal vein occlusion. Can J Ophthalmol 30:21–24
Costa RA, Jorge R, Calucci D, Melo LA Jr, Cardillo JA, Scott IU (2007) Intravitreal bevacizumab (avastin) for central and hemicentral retinal vein occlusions: IBeVO study. Retina 27:141–149
David R, Zangwill L, Badarna M, Yassur Y (1988) Epidemiology of retinal vein occlusion and its association with glaucoma and increased intraocular pressure. Ophthalmologica 197:69–74
Fekrat S, Finkelstein D (1999) Venous occlusive disease. In: Regillo CD, Brown GC, Flynn HW (eds) Vitreoretinal disease: the essentials, 1st edn. Thieme, New York
Green W, Chan C, Hutchins G (1981) Central retinal vein occlusions: a prospective histopathologic study of 29 eyes in 28 cases. Retina 1:27–55
Iturralde D, Spaide RF, Meyerle CB (2006) Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study. Retina 26:279–284
Jonas JB, Akkoyun I, Kamppeter B, Kreissig I, Degenring RF (2005) Intravitreal Triamcinolone acetonide for treatment of central retinal vein occlusion. Eur J Ophthalmol 15:751–758
Klein ML, Finkelstein D (1989) Macular grid photocoagulation for macular edema in central retinal vein occlusion. Arch Ophthalmol 107:1297–1302
Lang GE, Handel A (1992) Clinical and fluorescein angiography changes in patients with central retinal vein occlusion. A unicenter study of 125 patients. Klin Monbl Augenheilkd 201:302–308
Noma H, Funatsu H, Yamasaki M et al (2005) Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6. Am J Ophthalmol 140:256–261
Noma H, Funatsu H, Mimura T, Hori S (2008) Changes of vascular endothelial growth factor after vitrectomy for macular edema secondary to retinal vein occlusion. Eur J Ophthalmol 18:1017–1019
Priglinger SG, Wolf AH, Kreutzer TC (2007) Intravitreal bevacizumab injections for treatment of central retinal vein occlusion: six-month results of a prospective trial. Retina 27:1004–1012
Rogers S, McIntosh RL, Cheung N et al (2010) The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia. Ophthalmology 117:313–319
Sunness JS, Gass JDM, Singerman U (1991) Retinal and choroidal changes in pregnancy. In: Singerman U, Jampol LM (eds) Retinal and choroidal manifestations of systemic disease. Baltimore, Wiliams & Wiliams
The Branch Vein Occlusion Study Group (1984) Argon laser photocoagulation for macular edema in branch vein occlusion. The Branch Vein Occlusion Study Group. Am J Ophthalmol 98:271–282
Wolf-Schnurrbusch UEK, Ghanem R, Rothenbuehler SP, Enzmann V, Framme C, Wolf S (2011) Predictors of short-term visual outcome after anti-VEGF therapy of macular edema due to central retinal vein occlusion. Invest Ophthalmol Vis Sci 52:3334–3337
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer India
About this chapter
Cite this chapter
Wolf-Schnurrbusch, U.E.K. (2017). Retinal Vein Occlusion. In: Meyer, C., Saxena, S., Sadda, S. (eds) Spectral Domain Optical Coherence Tomography in Macular Diseases. Springer, New Delhi. https://doi.org/10.1007/978-81-322-3610-8_11
Download citation
DOI: https://doi.org/10.1007/978-81-322-3610-8_11
Published:
Publisher Name: Springer, New Delhi
Print ISBN: 978-81-322-3608-5
Online ISBN: 978-81-322-3610-8
eBook Packages: MedicineMedicine (R0)